Background
The MitraClip™ is a novel device for percutaneous mitral valve repair. Recent studies demonstrated a reduction of LV volumes after MitraClip™ implantation using echocardiography. CMR is currently the reference method to assess cardiac volumes but has not been used to assess LV remodeling after MitraClip™ implantation so far.
Methods
Twelve patients with functional (n=7) or degenerative (n=5) mitral valve regurgitation grade 3 to 4 underwent CMR at baseline (BL) before and at 6 month follow-up (FU) after successful MitraClip™ implantation. CMR protocol consisted of short-and long-axis slices using a steady-state-free-precession cine sequence for the assessment of LV, LA and RV volumes.
Results
Minor device-related artifacts were observed, enabling reliable delineation of endocardial borders in all patients at FU. Figure 1 ) demonstrates typical device-related artifacts 6 month after implantation (A) in comparison with a corresponding pre-implantation image (B). Mean intra-and inter-observer biases were 0.9±2.0 and 1.6 ±2.9 % for LV end-diastolic (LVEDV), 0.3±4.7 and 1.8 ±6.4 % for LV end systolic (LVESV), 0.1±2.9 and 2.2±3.7 % for RVEDV, 1.7±7.8 and 3.5±8.8 % for RVESV as well as 0.3±7.6 and 13.7±14.0 % for LA (LAV) volume indices at FU. No significant differences in intra-or inter-observer biases were observed between BL and FU. 
Conclusions
CMR enables reproducible measurements of cardiac volumes in patients with implanted MitraClip™ devices. Significantly decreased LV but unchanged LA and RV volumes were found at 6 month after successful MitraClip™ implantation. 
